Latest filing published 16 Jun 2025 for Vaxcyte, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Heath Lukatch (board member) discloses dealings in 3 companies, chiefly Vaxcyte, Inc., Flexion Therapeutics Inc and Inogen Inc. We count 15 filings; the first trade dates from 10 May 2021 and the latest from 12 June 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 16 June 2025, reports a share grant in Vaxcyte, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations